Frontiers Effects of Oral Glucose-Lowering Agents on Gut Microbiota and Microbial Metabolites

Por um escritor misterioso

Last updated 06 julho 2024

Frontiers Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Antihypertensive Treatment

Frontiers Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease

Frontiers The Human Gut Microbiome – A Potential Controller of Wellness and Disease

Frontiers Polyphenol-Mediated Gut Microbiota Modulation: Toward Prebiotics and Further

Bi-directional drug-microbiome interactions of anti-diabetics - eBioMedicine

Frontiers Pharmacomicrobiomics and type 2 diabetes mellitus: A novel perspective towards possible treatment

Frontiers Gut macrobiotic and its metabolic pathways modulate cardiovascular disease

Frontiers The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis

Frontiers Cross-Talk Between Gut Microbiota and Adipose Tissues in Obesity and Related Metabolic Diseases

Frontiers Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation

Recomendado para você